Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Something is cooking!!!

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Aug 22, 2023 2:36pm

105 Views

Post# 35600353

RE:Something is cooking!!!

I may be interpreting this wrong but the newly released Coporate Presentation is like a Term Sheet to be presented to eventual acquirer(s/partners ) in whole or in part .....
They will reduce expenses to the minimum until resolution

palinc2000 wrote: Restructuring? Take over? Merger? Partnering?
I may be wrong but the only other explanation would be that there has been a gas leak in the Head Office and they are all sleeping LOL!!!

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition